ONSIOR (robenacoxib) tablets are indicated for the control of postoperative pain and inf ammation associated with
orthopedic surgery, ovariohysterectomy and castration, in cats ≥ 5.5 lbs (2.5 kg) and ≥ 4 months of age; for up to a
maximum of 3 days. ONSIOR tablets should not be used in cats that have a hypersensitivity to robenacoxib or known
intolerance to NSAIDs. Do not administer ONSIOR tablets in conjunction with any other oral or injectable NSAID
or corticosteroid. The most commonly reported adverse reactions are surgical site bleeding, infected surgery sites,
lethargy, vomiting and inappetance. Please see product insert for full prescribing information or brief summary
on the following page for important product information.
www.us.onsior.com
Announcing a breakthrough in pain relief
for cats – Onsior
®
(robenacoxib).
•
In the f eld study,
over 80% of the Onsior treated cats did not need
rescue pain therapy, demonstrating that Onsior
(robenacoxib) tablets
for cats are effective.
•
Onsior provides
24 hours of pain relief with once-a-day administration
for up to
3 days. Onsior persists longer in the inflammatory exudate of a
tissue cage model than in the blood. The clinical significance is unknown.
•
The Onsior clinical field trial, along with the 6-month safety study, support
the
safe use for 3 days.
88% of veterinarians
agreed that Onsior
was EASILY ACCEPTED
by their patients
*
*
Analysis based on a 5-point scale from
very disagreeable to very agreeable.
© 2014 Novartis Animal Health US, Inc.
Onsior® is a registered trademark of Novartis AG. USONS140385
Just where it's needed. Relief.
TVP_2014-0506_FelinePainMgmt (Part 2).indd 29 5/23/2014 11:23:10 AM